Fundz

Salish Bioscience Inc. reported raising $7.04 Million in an initial SEC Form D filing, from an offering of $7.04 Million

PRIVATEApr 14, 2022

Amount Raised

$7.04 Million

$7.04 Million sold, per SEC Form D (first sale Apr 14, 2022)

Round Type

Venture

SeattleHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as Salish Bioscience Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Fuse Oncology, Inc. raised $3M (Seed) on May 27, 2022.
  • Digital Diagnostics Inc. raised $76M (Pre-Seed) on May 27, 2022.
  • Digital Diagnostics Inc. raised $46M on May 27, 2022.
  • Spesana Inc. raised $500K (Seed) on May 27, 2022.
  • CSFRefresh raised $70K (Pre-Seed) on May 27, 2022.
  • Choix, Inc. raised $1000K (Seed) on May 27, 2022.

Who to call at Salish Bioscience Inc., and when

A new round usually means Salish Bioscience Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Salish Bioscience Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Salish Bioscience Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Salish Bioscience Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Salish Bioscience Inc.

Location

3005 1st Avenue Suite 204

Seattle, Washington, United States

About

Salish is dedicated to advancing non-invasive cancer screenings in order to improve screening accuracy and to improve the quality of life for patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Salish Bioscience Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Salish Bioscience Inc.'s next move

See what Strategic adds

Salish Bioscience Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.